Tildrakizumab

MedChem Express

Tildrakizumab

10

Research Use Only

Monoclonal

99.46

Tildrakizumab (SCH 900222) is a humanized anti- IL-23 (p19 subunit) monoclonal antibody. IL-23 is a critical cytokine to maintain the Th17 cell phenotype. Tildrakizumab has high-affinity for single-chain IL-23 ( K d : 136 pM). Tildrakizumab is effective against moderate to severe plaque psoriasis [1] [2] [3] .

-80°C

12352203